Title of article
Tailoring Immunotherapy Treatment of Synchronous Renal CellCarcinoma (RCC) and Triple-Negative Breast Cancer (TNBC
Author/Authors
Ornstein , Moshe C. Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA , Sheng, Iris Y. Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA , Kruse, Megan Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA , Leininger, Kathryn M. Department of Hematology and Medical Oncology - Cleveland Clinic Taussig Cancer Institute - Cleveland - Ohio, USA
Pages
3
From page
1
To page
3
Abstract
Synchronous tumors are defined as two tumors arising concurrently or within six months of each other. Reports of synchronousRCC and breast cancer are limited to nonmetastatic renal cell carcinoma (RCC) and hormone receptor-positive infiltrativeductal carcinoma. We present thefirst case of synchronous metastatic renal cell carcinoma and metastatic triple-negative breastcancer, managed with a novel combination of immunotherapy and chemotherapy
Keywords
Tailoring Immunotherapy Treatment , Synchronous Renal Cell Carcinoma (RCC) , Triple-Negative Breast Cancer (TNBC) , SQSTM1-RET
Journal title
Case Reports in Oncological Medicine
Serial Year
2019
Record number
2610534
Link To Document